Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 308.65 INR -0.16% Market Closed
Market Cap: 139.9B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Relative Value

The Relative Value of one MARKSANS stock under the Base Case scenario is 175.98 INR. Compared to the current market price of 308.65 INR, Marksans Pharma Ltd is Overvalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MARKSANS Relative Value
Base Case
175.98 INR
Overvaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
32
Median 3Y
2
Median 5Y
1.7
Industry
2.5
Forward
5.2
vs History
1
vs Industry
17
Median 3Y
13.8
Median 5Y
11.9
Industry
21.9
Forward
35.7
vs History
1
vs Industry
11
Median 3Y
20.5
Median 5Y
17.5
Industry
16.5
vs History
vs Industry
5
Median 3Y
27.8
Median 5Y
22.4
Industry
23.6
vs History
1
vs Industry
18
Median 3Y
2.4
Median 5Y
2.5
Industry
2.1
vs History
1
vs Industry
31
Median 3Y
1.7
Median 5Y
1.5
Industry
2.6
Forward
5
vs History
1
vs Industry
30
Median 3Y
3.3
Median 5Y
2.8
Industry
5.2
vs History
1
vs Industry
21
Median 3Y
8.7
Median 5Y
7.5
Industry
13.3
Forward
24
vs History
1
vs Industry
20
Median 3Y
10.7
Median 5Y
8.9
Industry
16.6
Forward
28.3
vs History
1
vs Industry
12
Median 3Y
18.3
Median 5Y
15.3
Industry
15.6
vs History
1
vs Industry
1
Median 3Y
30.8
Median 5Y
21.7
Industry
19.1
vs History
1
vs Industry
18
Median 3Y
2.6
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

MARKSANS Competitors Multiples
Marksans Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Marksans Pharma Ltd
NSE:MARKSANS
139.9B INR 6.2 41.9 28.2 33.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
Marksans Pharma Ltd
NSE:MARKSANS
Average P/E: 33.6
41.9
96%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top